Jennifer Newton
As the daughter of a chemistry teacher, chemistry has always been in my blood. Teaching science for 5 weeks in Ghana when I was 16 confirmed my suspicions that I didn’t also want to be a teacher.
I studied natural sciences at the University Bath, doing a little bit of everything, mainly chemistry and pharmacology but no physics. My degree included a year-long industrial placement at the Defence Science and Technology Laboratory, part of the Ministry of Defence – although if I told you what I did there, I’d have to kill you.
I joined the Royal Society of Chemistry in September 2008, collecting over 4 years of experience in journals publishing, before moving to Chemistry World in April of 2013. Cooking and gardening dominate when I'm not at work.
BusinessShell shrinks stake in Canadian oil sands
$7.25bn sell-off is part of plan to divest over $30bn in assets to reduce debts
BusinessAramco and Shell end refining relationship
$2.2 billion divorce deal gives Aramco control of biggest oil refinery in the US
BusinessCristal deal will make Tronox world’s largest titanium dioxide producer
Tronox to sell alkali business to fund $1.67bn transaction
OpinionSupramolecular evolution
Can chemists embrace disequilibria like they have non-covalent interactions?
PodcastSpilanthol
It’s the active molecule in the plant known as electric daisies or the toothache plant but it might also make your skin smoother
BusinessFracking gets first UK approval for five years
Council says Third Energy can test existing borehole in North Yorkshire
BusinessPfizer to buy Anacor for eczema ointment
$5.2bn deal will bolster pharma giant’s inflammation and immunology drugs portfolio
OpinionChemistry under control
There’s more to influencing the science of change than temperature and catalysts
BusinessMEGlobal to build $1bn US petrochemical plant
Ethylene glycol company announces plans for first US facility
BusinessSanofi and Merck & Co end vaccines partnership
Two-decade-long alliance will split by end of 2016
BusinessDow to settle polyurethane price-fixing case
Chemical giant cancels Supreme Court appeal of damages and agrees $835m settlement
- Business
AstraZeneca to buy Acerta for blood cancer drug
Deal will strengthen AstraZeneca’s immunotherapy offering
- Business
Mexico approves world’s first dengue vaccine
Sanofi’s vaccine protects children and adults against the mosquito-borne disease
- Business
Pfizer to close Cambridge pain outpost
120 jobs under threat from closure of Neusentis subsidiary R&D site
